Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles.

about

Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines.

P2860

Q55286689-FB97B526-3CD0-4D01-875F-1BD5F156EF2E

P2860

Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles.

Item

http://www.wikidata.org/entity/Q49387572

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Targeting prostate cancer cell ...... eptide/liposome nanoparticles.

@en

Targeting prostate cancer cell ...... eptide/liposome nanoparticles.

@nl

type

Item

label

Targeting prostate cancer cell ...... eptide/liposome nanoparticles.

@en

Targeting prostate cancer cell ...... eptide/liposome nanoparticles.

@nl

prefLabel

Targeting prostate cancer cell ...... eptide/liposome nanoparticles.

@en

Targeting prostate cancer cell ...... eptide/liposome nanoparticles.

@nl

P1476

Targeting prostate cancer cell ...... peptide/liposome nanoparticles

@en

P2093

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Xiuli Guo

http://www.w3.org/2001/XMLSchema#string

Yunmei Song

http://www.w3.org/2001/XMLSchema#string

P2860

Formulation optimization and in vivo proof-of-concept study of thermosensitive liposomes balanced by phospholipid, elastin-like polypeptide, and cholesterol

Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate

Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.

Biodegradation of elastin-like polypeptide nanoparticles.

Comparative properties and methods of preparation of lipid vesicles (liposomes).

Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer

Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).

Docetaxel-loaded pluronic p123 polymeric micelles: in vitro and in vivo evaluation.

Contemporary experience with ketoconazole in patients with metastatic castration-resistant prostate cancer: clinical factors associated with PSA response and disease progression.

Current management of prostate cancer: dilemmas and trials

P304

293-305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S152485

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29391790

http://www.w3.org/2001/XMLSchema#string

P932

5768422

http://www.w3.org/2001/XMLSchema#string

Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles.

about

P2860

P2860

Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932